NEW YORK (GenomeWeb News) – The Sloan-Kettering Institute, part of the Memorial Sloan-Kettering Cancer Center, has licensed Geneva Bioinformatics’ PhenyxServer protein identification and characterization software, GeneBio said today.
 
Under the agreement, Sloan-Kettering researcher Paul Tempst will use the Phenyx protein identification and characterization software in its Clinical Proteomic Technology Assessment for Cancer group.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.